Pages that link to "Q45307199"
Jump to navigation
Jump to search
The following pages link to Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease. (Q45307199):
Displaying 50 items.
- Glutamate and neurotrophic factors in neuronal plasticity and disease (Q24653626) (← links)
- Domoic acid toxicologic pathology: a review (Q24657510) (← links)
- Calpain and STriatal-Enriched protein tyrosine phosphatase (STEP) activation contribute to extrasynaptic NMDA receptor localization in a Huntington's disease mouse model (Q28265056) (← links)
- Shaping the role of mitochondria in the pathogenesis of Huntington's disease (Q28384036) (← links)
- Homeostatic adaptations in brain energy metabolism in mouse models of Huntington disease (Q28390800) (← links)
- Metabolism in HD: still a relevant mechanism? (Q28394301) (← links)
- Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease (Q28594357) (← links)
- Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in Han Chinese (Q28943390) (← links)
- Mouse models of Huntington's disease and methodological considerations for therapeutic trials (Q30481208) (← links)
- Complexity and heterogeneity: what drives the ever-changing brain in Huntington's disease? (Q33619310) (← links)
- Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic mice (Q34017941) (← links)
- Mitochondrial calcium uptake capacity as a therapeutic target in the R6/2 mouse model of Huntington's disease (Q34046887) (← links)
- Altered manganese homeostasis and manganese toxicity in a Huntington's disease striatal cell model are not explained by defects in the iron transport system. (Q34071987) (← links)
- A signaling cascade of nuclear calcium-CREB-ATF3 activated by synaptic NMDA receptors defines a gene repression module that protects against extrasynaptic NMDA receptor-induced neuronal cell death and ischemic brain damage. (Q34174477) (← links)
- Altered Ca(2+) signaling in skeletal muscle fibers of the R6/2 mouse, a model of Huntington's disease (Q34409630) (← links)
- Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli (Q34605764) (← links)
- Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease (Q35645271) (← links)
- Mitochondria as a Therapeutic Target for Aging and Neurodegenerative Diseases (Q35807409) (← links)
- Ca(2+) handling in isolated brain mitochondria and cultured neurons derived from the YAC128 mouse model of Huntington's disease (Q35893954) (← links)
- Calcium Handling by Endoplasmic Reticulum and Mitochondria in a Cell Model of Huntington's Disease. (Q35906784) (← links)
- Dysregulation of mitochondrial calcium signaling and superoxide flashes cause mitochondrial genomic DNA damage in Huntington disease (Q36579470) (← links)
- N-methyl D-aspartate channels link ammonia and epithelial cell death mechanisms in Helicobacter pylori Infection (Q36857253) (← links)
- Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease. (Q36861129) (← links)
- Impairing the mitochondrial fission and fusion balance: a new mechanism of neurodegeneration (Q37019754) (← links)
- Mitochondria in neuroplasticity and neurological disorders (Q37216404) (← links)
- VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington's disease (Q37223339) (← links)
- Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration (Q37237452) (← links)
- Mutant huntingtin and mitochondrial dysfunction (Q37308357) (← links)
- Mitochondrial structural and functional dynamics in Huntington's disease (Q37356257) (← links)
- Mitochondrial calcium function and dysfunction in the central nervous system (Q37418288) (← links)
- Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease. (Q37427280) (← links)
- Early dysfunction and progressive degeneration of the subthalamic nucleus in mouse models of Huntington's disease (Q37544836) (← links)
- Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease (Q37557789) (← links)
- Mitochondrial medicine for neurodegenerative diseases (Q37672741) (← links)
- Mitochondrial quality control and neurological disease: an emerging connection (Q37732485) (← links)
- Dopamine and glutamate in Huntington's disease: A balancing act. (Q37734563) (← links)
- Mitochondrial functional alterations in relation to pathophysiology of Huntington's disease (Q37750542) (← links)
- The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease (Q37765841) (← links)
- The clinical and genetic features of Huntington disease (Q37798079) (← links)
- Screening of therapeutic strategies for Huntington's disease in YAC128 transgenic mice. (Q37866383) (← links)
- Energy dysfunction in Huntington's disease: insights from PGC-1α, AMPK, and CKB. (Q38013005) (← links)
- A mitochondrial basis for Huntington's disease: therapeutic prospects (Q38174451) (← links)
- Mutant Huntingtin and Elusive Defects in Oxidative Metabolism and Mitochondrial Calcium Handling (Q38458943) (← links)
- Ionomycin-induced calcium influx induces neurite degeneration in mouse neuroblastoma cells: analysis of a time-lapse live cell imaging system (Q38749124) (← links)
- Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy. (Q39712232) (← links)
- Opposing roles of synaptic and extrasynaptic NMDA receptor signaling in cocultured striatal and cortical neurons (Q41791746) (← links)
- Decreasing Levels of the cdk5 Activators, p25 and p35, Reduces Excitotoxicity in Striatal Neurons (Q42108493) (← links)
- 4-hydroxy-2(E)-Nonenal facilitates NMDA-Induced Neurotoxicity via Triggering Mitochondrial Permeability Transition Pore Opening and Mitochondrial Calcium Overload. (Q42936169) (← links)
- Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity (Q45291700) (← links)
- Transgenic Animal Models of Huntington’s Disease (Q45301195) (← links)